A gene therapy targeting medium-chain acyl-CoA dehydrogenase (MCAD) did not protect against diabetes-induced cardiac pathology
Authors:
- 21 November 2023
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 102 (1) , 95-111
Abstract
Diabetic cardiomyopathy describes heart disease in patients with diabetes who have no other cardiac conditions but have a higher risk of developing heart fKeywords
All Related Versions
Funding Information
- Baker Heart and Diabetes Institute (Women in Science Grant, Baker Fellowship)
- Diabetes Australia (Y19G-BERB, Y19G-BERB)
- National Heart Foundation of Australia (102539 (Future Leader Fellowship))
- Monash University (Research Training Program scholarship)
- National Health and Medical Research Council (1078985, 1117835, 2017070)
- National Health and Medical Research Council
This publication has 53 references indexed in Scilit:
- Cardiac-Specific Deletion of Acetyl CoA Carboxylase 2 Prevents Metabolic Remodeling During Pressure-Overload HypertrophyCirculation Research, 2012
- Nerve Growth Factor Gene Therapy Using Adeno-Associated Viral Vectors Prevents Cardiomyopathy in Type 1 Diabetic MiceDiabetes, 2011
- Evidence for Physical Association of Mitochondrial Fatty Acid Oxidation and Oxidative Phosphorylation ComplexesJournal of Biological Chemistry, 2010
- PI3K(p110α) Protects Against Myocardial Infarction-Induced Heart FailureArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Medium‐Chain Acyl‐CoA Dehydrogenase Deficiency in an Infant with Dilated CardiomyopathyCardiology Research and Practice, 2009
- Enhanced acyl-CoA dehydrogenase activity is associated with improved mitochondrial and contractile function in heart failureCardiovascular Research, 2008
- Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studiesBMJ, 2005
- Characterization of Wild-Type Human Medium-Chain Acyl-CoA Dehydrogenase (MCAD) and Mutant Enzymes Present in MCAD-Deficient Patients by Two-Dimensional Gel Electrophoresis: Evidence for Posttranslational Modification of the EnzymeBiochemical Medicine and Metabolic Biology, 1994
- Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham StudyDiabetes Care, 1979
- Role of diabetes in congestive heart failure: The Framingham studyThe American Journal of Cardiology, 1974